Stratos Wealth Partners, Ltd. Edwards Lifesciences Corp Transaction History

Stratos Wealth Partners, Ltd.

$6.79 Billion
Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 14,475 shares of EW stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,475

Previous 14,786 2.1%

Holding current value

$1.07 Million

Previous $1.37 Million 30.04%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$59.7 - $93.78 $18,566 - $29,165	-311 Reduced 2.1%	14,475 $955,000
Q2 2024 Jul 24, 2024	SELL	$84.3 - $94.31 $31,949 - $35,743	-379 Reduced 2.5%	14,786 $1.37 Million
Q1 2024 Apr 16, 2024	SELL	$72.54 - $95.56 $52,954 - $69,758	-730 Reduced 4.59%	15,165 $1.45 Million
Q4 2023 Jan 24, 2024	BUY	$61.71 - $77.76 $980,880 - $1.24 Million	15,895 New	15,895 $1.21 Million
Q1 2022 Apr 26, 2022	SELL	$101.96 - $128.34 $1.17 Million - $1.47 Million	-11,479 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$106.37 - $130.68 $1.22 Million - $1.5 Million	11,479 New	11,479 $1.49 Million
Q3 2021 Oct 19, 2021	SELL	$102.91 - $122.75 $1.13 Million - $1.35 Million	-10,989 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$83.84 - $104.76 $40,578 - $50,703	484 Added 4.61%	10,989 $1.14 Million
Q1 2021 Apr 27, 2021	SELL	$78.68 - $90.67 $38,710 - $44,609	-492 Reduced 4.47%	10,505 $879,000
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $12,975 - $16,512	181 Added 1.67%	10,997 $1 Million
Q3 2020 Oct 29, 2020	SELL	$67.19 - $87.44 $29,362 - $38,211	-437 Reduced 3.88%	10,816 $863,000
Q2 2020 Jul 28, 2020	BUY	$57.54 - $76.95 $427,982 - $572,354	7,438 Added 194.97%	11,253 $778,000
Q1 2020 May 04, 2020	BUY	$52.41 - $81.0 $34,905 - $53,946	666 Added 21.15%	3,815 $720,000
Q4 2019 Jan 29, 2020	BUY	$71.7 - $82.09 $29,038 - $33,246	405 Added 14.76%	3,149 $735,000
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $166,615 - $204,189	2,707 Added 7316.22%	2,744 $603,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $165,261 - $202,529	-2,685 Reduced 98.64%	37 $797,000
Q2 2019 Aug 06, 2019	SELL	$55.74 - $64.41 $88,013 - $101,703	-1,579 Reduced 36.71%	2,722 $503,000
Q1 2019 May 07, 2019	BUY	$47.89 - $64.05 $129,781 - $173,575	2,710 Added 170.33%	4,301 $823,000
Q4 2018 Feb 08, 2019	BUY	$46.41 - $56.94 $73,838 - $90,591	1,591 New	1,591 $244,000
Q3 2018 Nov 02, 2018	SELL	$45.7 - $58.03 $125,857 - $159,814	-2,754 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $29,757 - $35,961	-701 Reduced 20.29%	2,754 $401,000
Q1 2018 May 10, 2018	BUY	$37.19 - $47.45 $409 - $521	11 Added 0.32%	3,455 $482,000
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $18,787 - $21,900	556 Added 19.25%	3,444 $388,000
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $104,805 - $112,141	2,888	2,888 $316,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Edwards Lifesciences Corp Transaction History